ResMedvs.Zimmer Biomet
RMD vs ZBH · both in Medtech & devices, part of the Medicine, pharma & life science value chain: Medical equipment and devices — from surgery and cardiology to robotics.
ResMed is about 1.7× larger than Zimmer Biomet by market cap; ResMed trades at the lower P/E (19.6 vs 23.2); year to date, Zimmer Biomet leads (+1.6% vs −15.4%).
Side by side
| RMD | ZBH | |
|---|---|---|
| Market cap | $29.8B | $17.6B |
| Price | $203.87 | $91.34 |
| Today | −2.2% | +2.4% |
| Return YTD | −15.4% | +1.6% |
| Return 1Y | −21.0% | −4.0% |
| P/E | 19.6 | 23.2 |
| P/S | 5.4 | 2.1 |
| P/B | 4.6 | 1.4 |
Data as of 2026-07-11 · updates daily after U.S. close
The two companies
More comparisons in Medtech & devices
See where RMD and ZBH sit in the full Medicine, pharma & life science map — every segment from suppliers to end markets.Open the Life science value chain →